Clinical Trial Update: Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia

View source ↗

Summary

This clinical trial evaluated non-myeloablative allogeneic stem cell transplantation with matched unrelated donors across several hematologic malignancies, rena…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Aplastic Anemia
• Chronic Lymphocytic Leukemia
• Follicular Lymphoma
• Myelodysplastic Syndromes
• Non-hodgkin Lymphoma
• Renal Cell Carcinoma

Snippet

Sponsor: University of California, San Francisco | Conditions: Acute Myeloid Leukemia, Myelodysplasia | Status: COMPLETED